[PDF] clinicaleducation.org

[PDF][PDF] Sirtuins: novel targets for metabolic disease

PJ Elliott, M Jirousek - Current opinion in investigational drugs, 2008 - clinicaleducation.org
The identification of mammalian sirtuins (SIRTs; silent information regulator transcript) with
close homology to Sir2 from yeast is a recent discovery, which has ignited the field of caloric …
被引用次数：207 相关文章

Sirtuins: novel targets for metabolic disease.

PJ Elliott, M Jirousek - Current Opinion in Investigational Drugs …, 2008 - europepmc.org
Sirtuins represent a novel family of enzymes that are collectively well situated to help
regulate nutrient sensing and utilization, metabolic rate and ultimately metabolic disease …
[PDF] nutrilink.co.uk

[PDF][PDF] Sirtuins: Novel targets for metabolic disease

PJ Elliott, M Jirousek - Current Opinion in Investigational Drugs, 2008 - docs.nutrilink.co.uk
The identification of mammalian sirtuins (SIRTs; silent information regulator transcript) with
close homology to Sir2 from yeast is a recent discovery, which has ignited the field of caloric …

Sirtuins: Novel targets for metabolic disease

PJ Elliott, M Jirousek - Current Opinion in Investigational Drugs, 2008 - hero.epa.gov
Sirtuins represent a novel family of enzymes that are collectively well situated to help
regulate nutrient sensing and utilization, metabolic rate and ultimately metabolic disease …

Sirtuins: novel targets for metabolic disease

PJ Elliott, M Jirousek - Current opinion in investigational …, 2008 - pubmed.ncbi.nlm.nih.gov
Sirtuins represent a novel family of enzymes that are collectively well situated to help
regulate nutrient sensing and utilization, metabolic rate and ultimately metabolic disease …